TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

HUTH/23/003 PromethION DNA / RNA Gene Sequencing Machine

Biomedical equipment
Research laboratory services
Yorkshire & Humber (UKE11)
Yorkshire & Humber (UKE12)
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Hull University Teaching Hospitals NHS Trust: "HUTH/23/003 PromethION DNA / RNA Gene Sequencing Machine". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityHull University Teaching Hospitals NHS TrustScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Hull University Teaching Hospitals NHS Trust
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Hull University Teaching Hospitals NHS Trust. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
4.2Bids / Report
23.3% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 50 active published awards; 43 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityHull University Teaching Hospitals NHS Trust
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published11 Jan 2023, 15:58 GMT
Last source update11 Jan 2023, 15:58 GMT
Recurring procurementNot published
ClassificationBiomedical equipment, Research laboratory services
Delivery area
Yorkshire & Humber (UKE11)
Yorkshire & Humber (UKE12)
OCIDocds-h6vhtk-0396af
What is being bought
This notice is being published to inform of an award of a contract to Oxford Nanopore Technologies for a PromethION DRA / RNA Gene Sequencer.
What changed
From the official release history
  1. Status changed to complete
    11 Jan 2023, 15:58 GMT
  2. Official notice release published
    11 Jan 2023, 15:58 GMT
  3. Buyer information updated
    11 Jan 2023, 15:58 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    Status not published
    Published valueNot published
    The Trust has been awarded external UKRI funding to purchase an Oxford Nanopore Technologies (ONT) Promethion 24 sequencing device. This is to support several defined long-read sequencing projects, and wider research objectives. A condition of the funding is that this must be delivered by the end of March 2023.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    11 Jan 2023, 15:58 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 11 Jan 2023, 00:00 GMT · £398,001
Commercial outcome and competition
Awards
Oxford Nanopore Technologies
Not published · Not published · active
Contracts
Contract
£398,001 · signed 11 Jan 2023, 00:00 GMT · active
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

Hull University Teaching Hospitals NHS Trust

Contracting authority GB-FTS-68
View buyer profile

  • Hull University Teaching Hospitals NHS Trust
    buyer

    Supplies Building, Hull Royal Infirmary, Anlaby Road, Hull, UKE11, HU3 2JZ
    marcus.raw@nhs.net
    +44 1482608735

  • Hull University Teaching Hospitals NHS Trust
    reviewBody

    Kingston Upon Hull

  • Oxford Nanopore Technologies
    supplier

    Oxford, UKJ14
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThe Trust has been awarded external UKRI funding to purchase an Oxford Nanopore Technologies (ONT) Promethion 24 sequencing device. This is to support several defined long-read sequencing projects, and wider research objectives. A condition of the funding is that this must be delivered by the end of March 2023. Metagenomics is a rapidly emerging field, evaluating the composition and function of the microorganisms that inhabit an environment (eg. body sites/clinical samples). The interactions between these microorganisms and our bodies cells are important for both health and pathology. From the research undertaken by the Trust we understand that ONT is the sole provider of long-read nanopore sequencing, in particular: 1. ONT Promethion is able to deliver >30M long-read RNA and DNA sequences from any metagenomic sample from a single flow cell. The sequences are routinely >3Kb in length. The ONT technology is able to uniquely deliver sub-species level characterisation of community composition. 2. ONT Promethion includes real-time adaptive sequencing capabilities. This means that samples can be enriched for specific sequences during the data generation which is essential to overcome host contamination in clinical metagenomics samples.